Curcumol ameliorates diabetic retinopathy <i>via</i> modulating fat mass and obesity-associated protein-demethylated MAF transcription factor G antisense RNA 1
Curcumol ameliorates the progression of DR by modulating the FTO/MAFG-AS1 axis, providing a novel therapeutic pathway for the treatment of DR. These findings suggest that curcumol-based therapies could offer a promising alternative for managing this debilitating complication of diabetes.
Authors
- Yu‐Feng Hu (ORCID: https://orcid.org/0000-0001-5715-2070)
- Wei Wei (ORCID: https://orcid.org/0000-0003-4456-840X)
- Rong Han (ORCID: https://orcid.org/0000-0003-3525-3983)
Institutions
- Nanjing University of Chinese Medicine (CN)
- Xuzhou Medical College (CN)
- Second People’s Hospital of Huai’an (CN)
Publication Details
- Journal
- World Journal of Diabetes
- Published
- 2025-02-28
- DOI
- https://doi.org/10.4239/wjd.v16.i4.97201
- Citations
- 1
- Primary Topic
- RNA regulation and disease
- Type
- article
- Field-Weighted Citation Impact
- 0.81